In vitro DNA repair genomics using XR-seq with <i>Escherichia coli</i> and mammalian cell-free extracts.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 37844222.
- Also identified by DOI 10.1073/pnas.2314233120 and PMC identifier 10614213.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
The XR-seq (eXcision Repair-sequencing) method has been extensively used to map nucleotide excision repair genome-wide in organisms ranging from <i>Escherichia coli</i> to yeast, <i>Drosophila</i>, Arabidopsis, mice, and humans. The basic feature of the method is to capture the excised oligomers carrying DNA damage, sequence them, and align their sequences to the genome. We wished to perform XR-seq in vitro with cell-free extract supplemented with a damaged DNA substrate so as to have greater flexibility in investigating factors that affect nucleotide excision repair in the cellular context [M. J. Smerdon, J. J. Wyrick, S. Delaney, <i>J. Biol. Chem.</i> <b>299</b>, 105118 (2023)]. We report here the successful use of ultraviolet light-irradiated plasmids as substrates for repair in vitro and in vivo by <i>E. coli</i> and <i>E. coli</i> cell-free extracts and by mammalian cell-free extract. XR-seq analyses demonstrated common excision product length and sequence characteristics in vitro and in vivo for both the bacterial and mammalian systems. This approach is expected to help understand the effects of epigenetics and other cellular factors and conditions on DNA repair.
Medical subject headings
- Escherichia coli
- DNA Repair